Last reviewed · How we verify

sirolimus (drug), mmf (drug) — Competitive Intelligence Brief

sirolimus (drug), mmf (drug) (sirolimus (drug), mmf (drug)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immunosuppressive agents (mTOR inhibitor + IMPDH inhibitor combination). Area: Immunology / Transplantation.

marketed Immunosuppressive agents (mTOR inhibitor + IMPDH inhibitor combination) mTOR (sirolimus); IMPDH type II (MMF) Immunology / Transplantation Small molecule Live · refreshed every 30 min

Target snapshot

sirolimus (drug), mmf (drug) (sirolimus (drug), mmf (drug)) — University Hospital Muenster. Sirolimus and MMF are immunosuppressive agents that work together to prevent organ rejection by inhibiting T-cell proliferation through different pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
sirolimus (drug), mmf (drug) TARGET sirolimus (drug), mmf (drug) University Hospital Muenster marketed Immunosuppressive agents (mTOR inhibitor + IMPDH inhibitor combination) mTOR (sirolimus); IMPDH type II (MMF)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immunosuppressive agents (mTOR inhibitor + IMPDH inhibitor combination) class)

  1. University Hospital Muenster · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). sirolimus (drug), mmf (drug) — Competitive Intelligence Brief. https://druglandscape.com/ci/sirolimus-drug-mmf-drug. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: